Long-term outcome of endoprosthetic replacement for proximal femur giant cell tumor

Introduction: Giant cell tumor (GCT) of bone is locally aggressive benign tumor involving the epiphysis of long bones in young adults. Various treatment options include intralesional curettage, extended curettage, wide resection, resection and reconstruction and amputation. The main variables to be...

Full description

Bibliographic Details
Main Authors: Gurinder Singh Gosal, Avneet Boparai, Gurpreet Singh Makkar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Nigerian Journal of Surgery
Subjects:
Online Access:http://www.nigerianjsurg.com/article.asp?issn=1117-6806;year=2015;volume=21;issue=2;spage=143;epage=145;aulast=Gosal
_version_ 1819229158280003584
author Gurinder Singh Gosal
Avneet Boparai
Gurpreet Singh Makkar
author_facet Gurinder Singh Gosal
Avneet Boparai
Gurpreet Singh Makkar
author_sort Gurinder Singh Gosal
collection DOAJ
description Introduction: Giant cell tumor (GCT) of bone is locally aggressive benign tumor involving the epiphysis of long bones in young adults. Various treatment options include intralesional curettage, extended curettage, wide resection, resection and reconstruction and amputation. The main variables to be considered for planning treatment include the site of involvement and Campanacci stage of the tumor. Functional and oncological outcomes of these treatment options vary widely, the predominant detrimental factor being tumor recurrence rate. Aim: A study was conducted to evaluate the long-term oncological and functional outcome of patients with GCT of the proximal femur that underwent tumor resection and endoprosthetic replacement. Materials and Methods: Eleven patients with Campanacci stage-III GCT of proximal femur who underwent wide excision of tumor and endoprosthesis replacement with a mean follow-up the duration of 10.6 years were assessed using standard proforma. The treatment outcome was evaluated using the Revised Musculoskeletal Tumor Society Rating Scale for the lower extremity. Results: At mean follow-up the duration of 10.6 years, none of the cases had tumor recurrence, infection, prosthesis loosening or dislocation. All the patients were community ambulators among whom eight patients were walking without support while three patients were using a cane for support. The mean total Musculoskeletal Tumor Society Score was 26.8 out of 30 indicating the good outcome. Conclusions: The authors recommend that wide resection and endoprosthetic replacement should be considered as a preferred treatment option for proximal femur GCT as the functional, and oncological outcome is satisfactory with this modality of treatment.
first_indexed 2024-12-23T11:08:43Z
format Article
id doaj.art-ed0906530e6b4bb4a04e1e7adf70d437
institution Directory Open Access Journal
issn 1117-6806
2278-7100
language English
last_indexed 2024-12-23T11:08:43Z
publishDate 2015-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Nigerian Journal of Surgery
spelling doaj.art-ed0906530e6b4bb4a04e1e7adf70d4372022-12-21T17:49:24ZengWolters Kluwer Medknow PublicationsNigerian Journal of Surgery1117-68062278-71002015-01-0121214314510.4103/1117-6806.162583Long-term outcome of endoprosthetic replacement for proximal femur giant cell tumorGurinder Singh GosalAvneet BoparaiGurpreet Singh MakkarIntroduction: Giant cell tumor (GCT) of bone is locally aggressive benign tumor involving the epiphysis of long bones in young adults. Various treatment options include intralesional curettage, extended curettage, wide resection, resection and reconstruction and amputation. The main variables to be considered for planning treatment include the site of involvement and Campanacci stage of the tumor. Functional and oncological outcomes of these treatment options vary widely, the predominant detrimental factor being tumor recurrence rate. Aim: A study was conducted to evaluate the long-term oncological and functional outcome of patients with GCT of the proximal femur that underwent tumor resection and endoprosthetic replacement. Materials and Methods: Eleven patients with Campanacci stage-III GCT of proximal femur who underwent wide excision of tumor and endoprosthesis replacement with a mean follow-up the duration of 10.6 years were assessed using standard proforma. The treatment outcome was evaluated using the Revised Musculoskeletal Tumor Society Rating Scale for the lower extremity. Results: At mean follow-up the duration of 10.6 years, none of the cases had tumor recurrence, infection, prosthesis loosening or dislocation. All the patients were community ambulators among whom eight patients were walking without support while three patients were using a cane for support. The mean total Musculoskeletal Tumor Society Score was 26.8 out of 30 indicating the good outcome. Conclusions: The authors recommend that wide resection and endoprosthetic replacement should be considered as a preferred treatment option for proximal femur GCT as the functional, and oncological outcome is satisfactory with this modality of treatment.http://www.nigerianjsurg.com/article.asp?issn=1117-6806;year=2015;volume=21;issue=2;spage=143;epage=145;aulast=GosalEndoprosthesis megaprosthesisgiant cell tumor of boneproximal femur
spellingShingle Gurinder Singh Gosal
Avneet Boparai
Gurpreet Singh Makkar
Long-term outcome of endoprosthetic replacement for proximal femur giant cell tumor
Nigerian Journal of Surgery
Endoprosthesis megaprosthesis
giant cell tumor of bone
proximal femur
title Long-term outcome of endoprosthetic replacement for proximal femur giant cell tumor
title_full Long-term outcome of endoprosthetic replacement for proximal femur giant cell tumor
title_fullStr Long-term outcome of endoprosthetic replacement for proximal femur giant cell tumor
title_full_unstemmed Long-term outcome of endoprosthetic replacement for proximal femur giant cell tumor
title_short Long-term outcome of endoprosthetic replacement for proximal femur giant cell tumor
title_sort long term outcome of endoprosthetic replacement for proximal femur giant cell tumor
topic Endoprosthesis megaprosthesis
giant cell tumor of bone
proximal femur
url http://www.nigerianjsurg.com/article.asp?issn=1117-6806;year=2015;volume=21;issue=2;spage=143;epage=145;aulast=Gosal
work_keys_str_mv AT gurindersinghgosal longtermoutcomeofendoprostheticreplacementforproximalfemurgiantcelltumor
AT avneetboparai longtermoutcomeofendoprostheticreplacementforproximalfemurgiantcelltumor
AT gurpreetsinghmakkar longtermoutcomeofendoprostheticreplacementforproximalfemurgiantcelltumor